People who receive AstraZeneca’s COVID-19 vaccine have a slightly increased risk of bleeding problems, according to a study published June 9 in Nature Medicine. Researchers observed adults in Scotland ...
FDA advisory panel backs AstraZeneca’s Truqap as the first targeted therapy for PTEN deficient metastatic hormone sensitive prostate cancer. The same panel issues a negative vote on breast cancer drug ...
Regulatory Recon is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. A story’s inclusion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results